| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3214985 | Journal of Investigative Dermatology | 2015 | 6 Pages |
Abstract
Identification of oncogenic BRAF mutations in primary and metastatic melanomas supports a linear model of clonal evolution in cancer. Some mutational studies, however, have failed to identify BRAF mutations in metastatic tumors from patients with BRAFmutant primary melanomas. Using a combination of methods, Riveiro-Falkenbach et al. (2015) assert that technical issues, and not clonal heterogeneity, may explain prior discordant mutational results.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Gregory A. Chang, David Polsky,